Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01439971 | Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia | PHASE1 | COMPLETED | 29 | — | — | Dec 1, 2011 | Oct 1, 2015 | May 11, 2017 | - | — |
| Name | Type | Description |
|---|---|---|
| PF-05280602 | BIOLOGICAL | 0.5 micrograms per kilogram of PF-05280602, IV infusion, single dose |